An increase in the incidence of inflammatory arthritis after COVID-19 has been reported.
Since many diseases exhibit population-specific causal effect sizes, we aimed to evaluate …

Background Given the widespread impact of COVID-19, it is important to explore any
atypical presentations and long-term sequelae associated with this viral infection, including …

Background Various musculoskeletal and autoimmune manifestations have been described
in patients with coronavirus disease 2019 (COVID-19). Objectives This study aims to …

Objectives The aim of this study is to evaluate risk factors for severe coronavirus disease
2019 (COVID-19) in patients with immune-mediated rheumatic diseases, stratified by …

As the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) continues to spread rapidly, there are still many …

Objective Rheumatoid arthritis (RA) and its treatments are associated with an increased risk
of infection, but it remains unclear whether these factors have an impact on the risk or …

Objectives To investigate the association between severe acute respiratory syndrome-
associated coronavirus-2 (SARS-CoV-2) infection and subsequent development of …

Objective Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring
infections owing to immunologic dysfunction and use of potent immunomodulatory …

The severe acute respiratory syndrome coronavirus 2-induced coronavirus disease 2019
(COVID-19) has had a global spread. Vaccines play an essential role in preventing the …

Objective To describe clinical characteristics of patients with rheumatic and musculoskeletal
diseases (RMDs) and immunosuppressive therapies with Coronavirus disease 2019 …